Nothing Special   »   [go: up one dir, main page]

IL114459A0 - Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases - Google Patents

Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases

Info

Publication number
IL114459A0
IL114459A0 IL11445995A IL11445995A IL114459A0 IL 114459 A0 IL114459 A0 IL 114459A0 IL 11445995 A IL11445995 A IL 11445995A IL 11445995 A IL11445995 A IL 11445995A IL 114459 A0 IL114459 A0 IL 114459A0
Authority
IL
Israel
Prior art keywords
treatment
effectiveness
monitoring
detecting
cell mediated
Prior art date
Application number
IL11445995A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL11445995A priority Critical patent/IL114459A0/xx
Publication of IL114459A0 publication Critical patent/IL114459A0/xx
Priority to IL12275696A priority patent/IL122756A/en
Priority to EP96923689A priority patent/EP0847281B1/en
Priority to DE69627161T priority patent/DE69627161T2/de
Priority to JP50531897A priority patent/JP3905126B2/ja
Priority to AU64543/96A priority patent/AU6454396A/en
Priority to AT96923689T priority patent/ATE235922T1/de
Priority to PCT/US1996/011374 priority patent/WO1997002052A1/en
Priority to US08/973,782 priority patent/US6309847B1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Ecology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
IL11445995A 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases IL114459A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases
IL12275696A IL122756A (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases
EP96923689A EP0847281B1 (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases
DE69627161T DE69627161T2 (de) 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen
JP50531897A JP3905126B2 (ja) 1995-07-05 1996-07-02 T細胞媒介疾患の治療の効力を検出又は監視する方法
AU64543/96A AU6454396A (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treament of t cell mediated diseases
AT96923689T ATE235922T1 (de) 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen
PCT/US1996/011374 WO1997002052A1 (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases
US08/973,782 US6309847B1 (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of T cell mediated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases

Publications (1)

Publication Number Publication Date
IL114459A0 true IL114459A0 (en) 1995-11-27

Family

ID=11067728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases

Country Status (7)

Country Link
EP (1) EP0847281B1 (ja)
JP (1) JP3905126B2 (ja)
AT (1) ATE235922T1 (ja)
AU (1) AU6454396A (ja)
DE (1) DE69627161T2 (ja)
IL (1) IL114459A0 (ja)
WO (1) WO1997002052A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022697A (en) * 1996-11-29 2000-02-08 The Regents Of The University Of California Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
AU2003209623A1 (en) * 2002-02-19 2003-09-09 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
US8691772B2 (en) * 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006630A1 (en) * 1994-08-26 1996-03-07 The Regents Of The University Of California Methods and compositions for modulating a t cell response

Also Published As

Publication number Publication date
EP0847281A1 (en) 1998-06-17
DE69627161D1 (de) 2003-05-08
DE69627161T2 (de) 2004-02-19
JP2001520740A (ja) 2001-10-30
EP0847281B1 (en) 2003-04-02
ATE235922T1 (de) 2003-04-15
WO1997002052A1 (en) 1997-01-23
AU6454396A (en) 1997-02-05
JP3905126B2 (ja) 2007-04-18
EP0847281A4 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
NL1008619A1 (nl) Werkwijze voor het meten en aangeven van de mate waarin een persoon beperkt is in activiteiten van het dagelijks leven.
EP1113385A3 (en) Device and method for sensing data input
EP0653718A3 (de) Vorrichtung und Verfahren zur Erfassung körperspezifischer Messdaten.
DE69940470D1 (de) Vorrichtung und verfahren für die thermometrie
IL126544A0 (en) Analyte assay using particulate labels
CY1108397T1 (el) Αντι-ccr4 αντισωμα και θραυσμα αυτου
EP0445618A3 (en) Device and procedure to measure without contact the surface-contour of an object
EP0702978A3 (en) Apparatus for treating obstructive sleep apnea
EP0311439A3 (en) Ozone gas sensor and ozone gas detecting device having ozone gas sensor
PT1148816E (pt) Protecções de dentes e métodos de detecção do ranger dos dentes
EP1178536A3 (en) Image reading apparatus
DE68915372D1 (de) Gerät zum Wiegen und zur Grössenmessung von Personen.
IL114459A0 (en) Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases
DE69127495D1 (de) Erkennungseinheit und Gerät zur Erkennung und Beurteilung in dem die Einheit verwendet ist
FR2651036B1 (fr) Dispositif capteur delivrant des indications de pression et de temperature
WO2001029070A8 (en) Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
DK0984723T3 (da) Kardiovaskulær monitor
EP0296769A3 (en) Ophthalmic disease detection method and apparatus
ATA2289A (de) Vorrichtung zur messung des blutdruckes am menschlichen oder tierischen koerper
JPH03222941A (ja) 入眠判定装置
EP0738103A3 (de) Verfahren und Vorrichtung zum vollautomatischen Handhaben von elektrisch zu prüfenden Prüflingen
EP0782863A4 (en) ANTIBODY REAGENT TO DETECT AND USE THE ANEURYSMA DISSECAN OF THE AORTA
CN218010369U (zh) 一种医用中医针灸拔针检测仪
AU2001266983A1 (en) Adjuvants and processes to induce a specific type of immune response
FR2595670B3 (fr) Dispositif permettant de delivrer un par un des objets mis en vrac ayant des formes et des tailles variees